Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
PTGX Protagonist Therapeutics, Inc	$2.51B	$0 0.0% of portfolio	0	Q4 2024 New
PLX Protalix Bio Therapeutics, Inc.	$126M	$0 0.0% of portfolio	0	Q4 2024 New
TARA Protara Therapeutics, Inc.	$52.3M	$0 0.0% of portfolio	0	Q4 2024 New
PRTA Prothena Corp Public LTD CO	$627M	$0 0.0% of portfolio	0	Q4 2024 New
PTCT Ptc Therapeutics, Inc.	$4.03B	$0 0.0% of portfolio	0	Q4 2024 New
PBYI Puma Biotechnology, Inc.	$156M	$0 0.0% of portfolio	0	Q4 2024 New
PRTC Pure Tech Health PLC	$469M	$0 0.0% of portfolio	0	Q4 2024 New
PYXS Pyxis Oncology, Inc.	$41.1M	$0 0.0% of portfolio	0	Q4 2024 New
QSI Quantum Si Inc	$168M	$0 0.0% of portfolio	0	Q4 2024 New
RLYB Rallybio Corp	$21.2M	$0 0.0% of portfolio	0	Q4 2024 New
RANI Rani Therapeutics Holdings, Inc.	$35.5M	$0 0.0% of portfolio	0	Q4 2024 New
RAPT Rapt Therapeutics, Inc.	$46.3M	$0 0.0% of portfolio	0	Q4 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$1.18B	$0 0.0% of portfolio	0	Q4 2024 New
RGNX Regenxbio Inc.	$355M	$0 0.0% of portfolio	0	Q4 2024 New
RGLS Regulus Therapeutics Inc.	$19M	$0 0.0% of portfolio	0	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$344M	$0 0.0% of portfolio	0	Q4 2024 New
RLMD Relmada Therapeutics, Inc.	$9.15M	$0 0.0% of portfolio	0	Q4 2024 New
RNXT Renovo Rx, Inc.	$9.61M	$0 0.0% of portfolio	0	Q4 2024 New
RPTX Repare Therapeutics Inc.	$43.2M	$0 0.0% of portfolio	0	Q4 2024 New
REPL Replimune Group, Inc.	$527M	$0 0.0% of portfolio	0	Q4 2024 New
REVB Revelation Biosciences, Inc.	$67.8M	$0 0.0% of portfolio	0	Q4 2024 New
RVPH Reviva Pharmaceuticals Holdings, Inc.	$22.9M	$0 0.0% of portfolio	0	Q4 2024 New
RVMD Revolution Medicines, Inc.	$3.37B	$0 0.0% of portfolio	0	Q4 2024 New
RZLT Rezolute, Inc.	$116M	$0 0.0% of portfolio	0	Q4 2024 New
RYTM Rhythm Pharmaceuticals, Inc.	$2.95B	$0 0.0% of portfolio	0	Q4 2024 New
RCKT Rocket Pharmaceuticals, Inc.	$618M	$0 0.0% of portfolio	0	Q4 2024 New
ROIV Roivant Sciences Ltd.	$7.52B	$0 0.0% of portfolio	0	Q4 2024 New
RUBY Rubius Therapeutics, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
SABSW Sab Biotherapeutics Inc Wt Exp	$0	$0 0.0% of portfolio	0	Q4 2024 New
SAGE Sage Therapeutics, Inc.	$507M	$0 0.0% of portfolio	0	Q4 2024 Sold Out
SANA Sana Biotechnology, Inc.	$409M	$0 0.0% of portfolio	0	Q4 2024 New
SGMO Sangamo Therapeutics, Inc	$132M	$0 0.0% of portfolio	0	Q4 2024 New
SVRA Savara Inc	$311M	$0 0.0% of portfolio	0	Q4 2024 New
SRRK Scholar Rock Holding Corp	$1.68B	$0 0.0% of portfolio	0	Q4 2024 New
SCPH Sc Pharmaceuticals Inc.	$85.5M	$0 0.0% of portfolio	0	Q4 2024 New
SEER Seer, Inc.	$106M	$0 0.0% of portfolio	0	Q4 2024 New
SLS Sellas Life Sciences Group, Inc.	$25.7M	$0 0.0% of portfolio	0	Q4 2024 New
SNSE Sensei Biotherapeutics, Inc.	$13.5M	$0 0.0% of portfolio	0	Q4 2024 New
MCRB Seres Therapeutics, Inc.	$88.1M	$0 0.0% of portfolio	0	Q4 2024 New
SESN Sesen Bio, Inc.	$127M	$0 0.0% of portfolio	0	Q4 2024 New
STTK Shattuck Labs, Inc.	$50.4M	$0 0.0% of portfolio	0	Q4 2024 New
SLN Silence Therapeutics PLC	$130M	$0 0.0% of portfolio	0	Q4 2024 New
SILO Silo Pharma, Inc.	$4.27M	$0 0.0% of portfolio	0	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
SIOX Sio Gene Therapies Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
SLGL Sol Gel Technologies Ltd.	$13.2M	$0 0.0% of portfolio	0	Q4 2024 New
SNGX Soligenix, Inc.	$103M	$0 0.0% of portfolio	0	Q4 2024 New
SRNE Sorrento Therapeutics, Inc.	$148M	$0 0.0% of portfolio	0	Q4 2024 New
SPRO Spero Therapeutics, Inc.	$29.1M	$0 0.0% of portfolio	0	Q4 2024 New
SWTX Spring Works Therapeutics, Inc.	$2.95B	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.